ArticleBMC infectious diseases2026
Secondary Aspergillus candidus infection in a lung cancer patient with a heavy smoking history: a case report.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAspergillus candidus (A. candidus), while an uncommon clinical isolate, represents an emerging cause of severe invasive fungal disease, particularly among individuals with compromised immunity. Patients with hematologic or solid tumor malignancies-especially those with concomitant structural lung damage, such as resulting from long-term heavy smoking-are at heightened risk. CASE PRESENTATION: We describe a case of chronic pulmonary aspergillosis caused by A. candidus in a 66-year-old man with untreated lung cancer. The patient had a 40-year history of heavy smoking, with known chronic bronchitis and emphysema. Bilateral pulmonary nodules had been identified two years prior, for which he had declined intervention. He presented with complaints of cough, productive sputum, and worsening dyspnea. Chest imaging revealed progression of his underlying malignancy, accompanied by inflammatory changes. Bronchoalveolar lavage fluid was obtained and cultured; mycological analysis yielded colonies morphologically consistent with A. candidus, an identification subsequently confirmed through internal transcribed spacer (ITS) sequencing-the current gold standard for fungal speciation.
conclusionsTo our knowledge, this represents the first reported case of A. candidus infection in a treatment-naïve lung cancer patient with an extensive smoking history. It underscores the importance of considering this pathogen in heavily smoking-related lung cancer cases and highlights diagnostic and therapeutic challenges in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.